Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00907101Phase 4Completed
Phase 4, open-label, single-arm trial of adapalene + benzoyl peroxide in acne vulgaris, sponsored by Galderma. Primary endpoint: Change From Baseline in Quantitative Bacteriology Measurements at 4 weeks. Started Jun 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00907101.